Novadip Biosciences Undisclosed stage: €10.4M

Sep 20, 2026Public sources — Collected from public sources, not yet cross-checked.

Novadip Biosciences raised €10.4 million (about $11.95 million) in an undisclosed stage round led by New Science Ventures, announced Sept. 20.

Facts

Company: Novadip Biosciences
Amount: €10.4 million (about $11.95 million)
Currency: EUR
Stage: Undisclosed stage
Announced: Sep 20, 2026
Instrument: Convertible note
FX rate: 1 EUR = 1.149 USD on Sep 20, 2026

Investors

Led by: New Science Ventures
Participants: Fund+Wallonie Entreprendre VIVES Fund ORSA Tech Sambrinvest Noshaq Invest.BW

Use of funds

Complete pivotal Phase 3 trial of NVD003 and unlock an EIB venture debt tranche.

As stated by the company.

Sources

1.Belgium’s Novadip Biosciences raises €10.4 million to fund pivotal clinical trial and unlock EIB loan tranche — EU-Startups, Sep 21, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026